46 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Rite Aid Corporation RAD shares jumped 47.2% to $12.24 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY20 EPS guidance above analyst estimates.
• Catalyst Biosciences Inc CBIO gained 44.2% to $6.88 following news of a license and collaboration deal with Biogen for a dry age-related macular degeneration treatment. The company will receive a $15 million upfront payment and be eligible for an added $340 million in milestones.
• Paratek Pharmaceuticals, Inc. PRTK shares climbed 35.4% to $3.9911. Paratek Pharmaceuticals said the Department of Human Health, Office of the Assistant Secretary for Preparedness and Response, and Biomedical Advanced Research and Development Authority, has awarded it a five-year contract, with an option to extend it to 10 years, to support the development of its Nuzyra for the treatment of pulmonary anthrax.
• Inovio Pharmaceuticals, Inc. INO rose 22.4% to $3.22. Roth Capital initiated coverage on Inovio Pharmaceuticals with a Buy rating and a $13 price target.
• PLx Pharma Inc. PLXP gained 19.1% to $4.0004.
• Conagra Brands, Inc. CAG rose 18.1% to $34.29 after the company reported upbeat earnings for its second quarter.
• Mirum Pharmaceuticals, Inc. MIRM shares jumped 15.7% to $27.50 after surging 44.1% on Wednesday.
• MSB Financial Corp. MSBF gained 15.4% to $17.54. Kearny Financial Corp. reported a merger with MSB Financial Corp.
• Axsome Therapeutics, Inc. AXSM rose 14.7% to $102.67. Axsome Therapeutics priced its 2 million share offering at $87 per share.
• GreenSky, Inc. GSKY rose 13.5% to $8.74. GreenSky reached an agreement in principle for a three-year, $6 billion forward flow arrangement with a leading institutional asset manager.
• Eyenovia, Inc. EYEN gained 13.3% to $3.75. Eyenovia disclosed that Professor Mark Bullimore, PhD and April Jasper, OD have joined Eyenovia’s Scientific Advisory Board.
• Clearside Biomedical, Inc. CLSD climbed 12.5% to $2.655.
• Abeona Therapeutics Inc. ABEO gained 11.4% to $4.39.
• PhaseBio Pharmaceuticals, Inc. PHAS surged 11.4% to $5.26.
• Millendo Therapeutics, Inc. MLND gained 10.4% to $6.89.
• REV Group, Inc. REVG climbed 10.3% to $12.99 after the company reported better-than-expected Q4 sales results. The company also issued FY20 sales guidance above analyst estimates.
• Karuna Therapeutics, Inc. KRTX shares surged 10% to $72.60. Stifel Nicolaus initiated coverage on Karuna Therapeutics with a Buy rating and a $126 price target.
• SpringWorks Therapeutics, Inc. SWTX gained 9.2% to $35.44.
• Stage Stores, Inc. SSI gained 8.9% to $6.34.
• Mosaic Acquisition Corp. MOSC rose 8.9% to $10.30 after the company announced that it entered into an amendment with Vivint Smart Home to merge with a subsidiary of Mosaic.
• Dropbox, Inc. DBX surged 8.6% to $18.67 on reports suggesting analysts believe the company is attracting strategic/activist interest.
• ImmunoGen, Inc. IMGN rose 8.3% to $5.38.
• Nordic American Tankers Limited NAT climbed 7.6% to $4.80
• TiVo Corp TIVO gained 7.5% to $8.48. The company reported it will merge with Xperi in a $3 billion deal.
• Match Group, Inc. MTCH rose 7.2% to $76.39 after the company announced an agreement with IAC to separate itself from the remaining businesses of IAC.
• Endo International plc ENDP gained 7% to $4.98.
• Rev Group Inc REVG rose 6.8% to $12.59 after the company reported better-than-expected Q4 sales results. The company also issued FY20 sales guidance above analyst estimates.
• Intelsat S.A. I shares rose 6.2% to $6.89 after gaining 8.89% on Wednesday.

Check out these big penny stock gainers and losers

Losers

• Apogee Enterprises, Inc. APOG fell 23% to $30.96 after the company reported worse-than-expected Q3 EPS and sales results. The company also cut FY20 EPS guidance below analyst estimates.
• Ekso Bionics Holdings Inc EKSO shares dipped 22.3% to $0.4199 after the company reported a $5 million registered direct offering at $0.45 per share.
• Venus Concept Inc. VERO dropped 17% to $4.77.
• Minerva Neurosciences, Inc. NERV fell 16.6% to $5.74. Minerva Neurosciences said the Phase 2b study that evaluated MIN-117 in adult patients with moderate to severe major depressive disorder, or MDD, failed to meet its primary and key secondary endpoints. The company said it has no plans for further clinical development of the molecule in MDD.
• Proteostasis Therapeutics, Inc. PTI dropped 15.6% to $1.30. The stock has dropped roughly 71% after the company reported results from its Phase 2 study evaluating CFTR Modulator combinations in F508del homozygous cystic fibrosis patients.
• Green Dot Corporation GDOT dropped 13.6% to $22.34 after the company reported the retirement of Founder and CEO Steve Streit. Citigroup downgraded Green Dot from Neutral to Sell and lowered the price target from $27 to $21.
• Quotient Technology Inc. QUOT fell 12.2% to $9.81. Morgan Stanley initiated coverage on Quotient Technology with an Underweight rating and an $8 price target.
• Herman Miller, Inc. MLHR fell 11.4% to $44.05 after the company reported worse-than-expected Q2 sales results. The company also issued Q3 EPS guidance below analyst estimates.
• Ascena Retail Group, Inc. ASNA fell 11.2% to $8.34. Ascena Retail reported a 1-for-20 reverse stock split, effective December 18, 2019.
• Xperi Corp XPER dipped 9% to $19.05. TiVo reported it will merge with Xperi in a $3 billion deal.
• Super League Gaming, Inc. SLGG shares dropped 7.8% to $2.61.
• Allakos Inc. ALLK dipped 7.6% to $110.22.
• BioNTech SE BNTX shares fell 6.2% to $32.82 after dropping 5.17% on Wednesday.
• Exicure, Inc. XCUR fell 6.1% to $2.78 after the company reported a common stock offering with no size disclosed.
• Groupon, Inc. GRPN shares declined 6.1% to $2.2450
• cbdMD, Inc. YCBD fell 5.8% to $2.93 after the company reported Q4 results.
• ASLAN Pharmaceuticals Limited ASLN fell 5.5% to $2.43 after gaining 10.30% on Wednesday.
• Darden Restaurants, Inc. DRI fell 4% to $111.75 after the company reported second-quarter earnings results.